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Probiotics are live microorganisms which when administered in adequate amounts confer
a health beneﬁt on the host.The main probiotic bacteria are strains belonging to the genera
Lactobacillus and Biﬁdobacterium, although other representatives, such as Bacillus or
Escherichia coli strains, have also been used. Lactobacillus and Biﬁdobacterium are two
common inhabitants of the human intestinal microbiota. Also, some species are used in
food fermentation processes as starters, or as adjunct cultures in the food industry. With
some exceptions, antibiotic resistance in these beneﬁcial microbes does not constitute a
safety concern in itself, when mutations or intrinsic resistance mechanisms are responsible
for the resistance phenotype. In fact, some probiotic strains with intrinsic antibiotic
resistance could be useful for restoring the gut microbiota after antibiotic treatment.
However, speciﬁc antibiotic resistance determinants carried on mobile genetic elements,
such as tetracycline resistance genes, are often detected in the typical probiotic genera, and
constitute a reservoir of resistance for potential food or gut pathogens, thus representing
a serious safety issue.
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INTRODUCTION
One of the most important selection criteria for bacterial strains
intended for use in the food industry is concern for their safety. In
Europe, according to the Qualiﬁed Presumption of Safety (QPS)
approach, established by the European Food Safety Authority
(EFSA, 2008), the nature of any antibiotic resistance determinant
present in a candidate microorganism should be determined prior
to approval for QPS status. Therefore, antibiotic resistance per se is
not a safety issue; it only becomes such when the risk of resistance
transfer is present.
Those probiotics belonging to species included in the EFSA
QPS list (EFSA, 2012) have excellent safety records, and detri-
mental effects produced as a consequence of their ingestion are
very scarce (Gouriet et al., 2012). Undoubtedly, a full safety assess-
ment begins with a proper identiﬁcation of the strain and an in
vitro evaluation of the potential risks. In this regard, the presence
of antibiotic resistance determinants, and their potential mobil-
ity, deserves special attention. Currently, it is generally accepted
that the possibility of transfer is related to the genetic basis of
the resistance mechanism, i.e., whether the resistance is intrinsic,
acquired as a result of a chromosomal mutation(s), or acquired by
horizontal gene transfer.
Most probiotics are common members of the human intesti-
nal tract, and they are ingested in large amounts in functional
foods, and the presence of antibiotic resistance determinants in
their genome must be systematically screened. For instance, the
biﬁdobacterial population in the human gut can be as high as
1011 cells/g of intestinal content, and even if the presence of the
resistance genes are not a threatwhen they are present in biﬁdobac-
terial cells due to their lack of infectivity, these cells can constitute
a reservoir from which genes could be transmitted to pathogenic
bacteria. Thus, it is of great interest to investigate whether these
determinants can be transferred in the food and gut environment
(Lahtinen et al., 2009). Furthermore, an important point to bear
in mind is that animal probiotics are a source of live bacteria in
the food chain, and in the European Union there has been an
active policy to eliminate transmissible resistances in these prod-
ucts. Such concern must be also expressed regarding consumption
of human probiotics.
In this review, we summarize the current knowledge on antibi-
otic resistance mechanisms in lactobacilli and biﬁdobacteria, as
well as in other potential probiotic candidates, such as Bacillus
strains. We did not consider enterococci because of the high preva-
lence of antibiotic resistance determinants in this genus and the
obvious safety concerns.
ANTIBIOTIC RESISTANCE DETERMINANTS IN Lactobacillus
The genus Lactobacillus is the largest group among the lactic
acid bacteria (LAB) and likely the most widely used as a pro-
biotic in a variety of foods, mainly meat and fermented dairy
products. To date, 182 species have been described within the
genus (list of prokaryotic names with standing in nomencla-
ture; www.bacterio.cict.fr/), giving an idea of its complexity. With
regard to antibiotic resistance, the vancomycin-resistant pheno-
type of some lactobacilli is perhaps the best characterized intrinsic
resistance in LAB. Vancomycin comes into contact with the pep-
tidoglycan precursors on the cell wall side of the cytoplasmic
membrane and binds to the D-alanine/D-alanine terminus of the
pentapeptide, preventing polymerization of peptidoglycan pre-
cursors. In several species of LAB, the terminal D-alanine residue
is replaced by D-lactate or D-serine in the muramylpentapep-
tide, preventing vancomycin binding (Delcour et al., 1999) and
therefore becoming resistant to the antibiotic. In addition, chro-
mosomal mutations leading to antibiotic resistance phenotypes
have also been described in lactobacilli. Flórez et al. (2007) identi-
ﬁed a single mutation in the 23S rRNA gene reducing the afﬁnity
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of erythromycin for the ribosome. This mutation conferred
macrolide resistance in a strain of L. rhamnosus. In this respect, the
transfer risk is considered to be very low for intrinsic resistance,
or acquired resistance due to chromosomal mutation(s). Never-
theless, knowledge of the antibiotic resistance phenotypes may
still be important, even in the absence of transferable resistance;
since lactobacilli are commonly used in food and feed products,
intrinsic resistance might still be relevant for the treatment of
Lactobacillus-related bacteremia (Cannon et al., 2005).
Horizontally transferred antibiotic resistance genes, particu-
larly those carried within mobile genetic elements, are the most
likely to be transmitted and thus deserve particular attention. A
major step in the differentiation between the intrinsic and the
acquired antibiotic resistance in probiotic bacteria is the deter-
mination and the comparison of antibiotic susceptibility patterns
of a representative number of different strains from each species.
Although some effort has been made to this end, work has only
been carried out for some antibiotics and particular Lactobacillus
species. These include the most commonly used probiotic species
such as L. casei, L. acidophilus, L. reuteri, or L. rhamnosus, among
others, or the yogurt starter bacteria L. delbrueckii (Ammor et al.,
2008b; Korhonen et al., 2008; Mayrhofer et al., 2010). However,
given the taxonomic complexity of this microbial genus, there
is still a lack of agreement on the resistance susceptibility break-
points for most antibiotics. The use of molecular methods, such as
microarray analysis and various PCR techniques is being extremely
helpful in determining the genetic basis of the acquired resis-
tance phenotypes. Moreover, the increasing availability of genome
sequences and the cost reduction of genome sequencing facilities
offer new possibilities for the screening of antimicrobial resistance
genes (Bennedsen et al., 2011).
With regard to speciﬁc antibiotics, lactobacilli are usually sen-
sitive to the cell wall-targeting penicillin and β-lactamase, but
are more resistant to cephalosporins. As previously mentioned,
many Lactobacillus species show a high level of resistance to van-
comycin. Also, most inhibitors of nucleic acid synthesis seem to
have a low inhibitory effect among the majority of Lactobacillus
species. On the other hand, lactobacilli are generally susceptible to
low concentrations of many inhibitors of protein synthesis, such
as chloramphenicol, macrolides, lincosamides, and tetracycline,
but their resistance to aminoglycosides is often high. Resistance to
other antibiotics varies greatly among lactobacilli.
Several genes responsible for atypical antibiotic resistance
properties among lactobacilli have been reported (Table 1). Chlo-
ramphenicol resistance genes (cat ; chloramphenicol acetyltrans-
ferases) have been identiﬁed in L. acidophilus, L. delbrueckii subsp.
bulgaricus (Hummel et al., 2007), and L. johnsonii (Mayrhofer
et al., 2010) as well as in L. reuteri (Lin et al., 1996) and L. plan-
tarum (Ahn et al., 1992). In addition, erythromycin resistance
genes, responsible for the macrolides, lincosamides, and strep-
togramins (MLS) resistance phenotype, have been identiﬁed in
several Lactobacillus species; the erm(B) gene, which encodes
a rRNA methylase acting on the 23S ribosomal subunit, is the
most frequently found of such genes, but others such as erm(A),
erm(C), or erm(T) have also been detected (van Hoek et al., 2008c;
Mayrhofer et al.,2010). Thepresenceof genes coding formacrolide
efﬂux pumps, such as mef(A), genes for lincosamide transferase
[lnu(A); Cauwerts et al., 2006] and streptogramin A acetyltrans-
ferases [vat(E); Gfeller et al., 2003; Mayrhofer et al., 2010] have
also been reported. However, the most common resistance deter-
minants found in lactobacilli are the tetracycline resistance genes,
which are sometimes found in combination (Ammor et al., 2008c).
At least 11different tetracycline resistance genes havebeendetected
to date in lactobacilli, these include genes coding for ribosomal
protection proteins [tet(W), tet(M), tet(S), tet(O), tet(Q), tet(36),
tet(Z), tet(O/W/32/O/W/O), tet(W/O)] and efﬂux pumps [tet(K)
and tet(L); Lahtinen et al., 2009]. Aminoglycoside resistance genes,
such as aac(6′)-aph(2′′), ant(6), and aph(3′)-IIIa (Rojo-Bezares
et al., 2006), and β-lactam resistance genes (blaZ) were found
much less frequently in lactobacilli (Aquilanti et al., 2007).
It is important to point out that many of the genetic deter-
minants mentioned above are sometimes found in potentially
mobile elements, such as transposons and plasmids, which could
spread the antibiotic resistance genesmainly by conjugationmech-
anisms. The localization of these genes within the genome, their
nucleotidic sequence, and the analysis of the ﬂanking regions
surrounding the antibiotic resistance genes may yield important
clues as to the acquisition process of these determinants, and their
source or origin (Aquilanti et al., 2007). Remarkably, some of these
genes have been found to be transferred in vitro between strains of
Lactobacillus and also from lactobacilli to different Gram-positive
bacteria, including food pathogens, such as Staphylococcus (Tan-
nock et al., 1994). On the other hand, lactobacilli may be able
to acquire antibiotic determinants from other Gram-positive bac-
teria (Vescovo et al., 1983). In addition to in vitro studies, the
potential risks associated with lactobacilli carrying transferable
antibiotic resistance determinants have also been demonstrated in
experimental animal models (Mater et al., 2008). The transfer of
these determinants may be enhanced in the presence of antibi-
otic selective pressure (Feld et al., 2008). Taken together, these
results support the hypothesis of the resistance gene reservoir
within intestinal bacteria, and their role as trafﬁckers in antibiotic
resistance genes.
Anothermechanismof resistance against antimicrobials known
to be present in certain lactobacilli is that mediated by multidrug
resistance (MDR) transporters. The role of drug resistance medi-
ated by MDR systems in lactobacilli has been the subject of a
previous review (Gueimonde et al., 2009). Although all lactobacilli
have MDR homologs, information in this regard is limited, with
only a few studies regarding the beer-spoiling L. brevis displaying
resistance to hop compounds (Sakamoto et al., 2001), a proton
motive force-dependent hop excretion transporter, named HorC,
found in L. lindneri (Suzuki et al., 2005), or a MDR protein found
to be involved in bile resistance in L. reuteri (Whitehead et al.,
2008).
ANTIBIOTIC RESISTANCE IN Biﬁdobacterium AND tet (W)
UBIQUITY
Biﬁdobacteria are members of the Actinobacteria phylum, one
of the main phylogenetic groups of the human gut microbiota
(Sánchez et al., 2013). Biﬁdobacterium infections are extremely
rare and have involved immunocompromised patients in a few
cases (Ohishi et al., 2010; Barberis et al., 2012; Jenke et al.,
2012), but, to the best of our knowledge, the ﬁve species of
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Table 1 | Antibiotic resistance determinants identified and characterized in lactobacilli, bifidobacteria, and probiotic Bacillus strains.
Gene(s) Resistance Mechanism Location Reference
Lactobacillus
blaZ β-Lactams Antibiotic hydrolysis – Aquilanti et al. (2007)
vat (E) Quinupristin–dalfopristin Antibiotic acetylation – Mayrhofer et al. (2010)
Cat Chloramphenicol Antibiotic acetylation Plasmid Ahn et al. (1992); Lin et al. (1996);
Hummel et al. (2007); Mayrhofer et al. (2010)
msrC MLS Efﬂux – Thumu and Halami (2012)
mef (A) Macrolide Efﬂux – Cauwerts et al. (2006)
aac(6′)-aph(2′ ′), ant (6),
aph(3′)-IIIa
Aminoglycoside Enzymatic modiﬁcation – Rojo-Bezares et al. (2006)
erm(B), erm(C), erm(T),
erm(LF), erm(GT), erm(A)
MLS Ribosomal methylation Plasmid, transposon,
chromosome
Tannock et al. (1994); Gfeller et al. (2003),
Cauwerts et al. (2006); Aquilanti et al. (2007),
Hummel et al. (2007); Klare et al. (2007),
Ammor et al. (2008b); Egervärn et al. (2009),
Mayrhofer et al. (2010); Thumu and Halami
(2012)
tet (W), tet (M), tet (S),
tet (O), tet (Q), tet (36),
tet (Z), tet (W/O),
tet (O/W/32/O/W/O)
Tetracycline Ribosomal protection Plasmid, transposon,
chromosome
Aquilanti et al. (2007); Klare et al. (2007),
Ammor et al. (2008b), van Hoek et al.
(2008b,c)
tet (K)/tet (L) Tetracycline Efﬂux Plasmid Aquilanti et al. (2007); Ammor et al. (2008c),
Devirgiliis et al. (2009); Thumu and Halami
(2012)
Biﬁdobacterium
erm(X) MLS Ribosomal methylation Transposon van Hoek et al. (2008a)
tet (W), tet (M), tet (O),
tet (W/32/O), tet (O/W)
Tetracycline Ribosomal protection Chromosome Flórez et al. (2006); Kazimierczak et al. (2006),
Ammor et al. (2008a); van Hoek et al. (2008b)
tet (L) Tetracycline Efﬂux Chromosome van Hoek et al. (2008b)
Bacillus
aaD2 Aminoglycoside Antibiotic adenylation Chromosome Bozdogan et al. (2003)
erm(34) MLS Ribosomal protection Chromosome Bozdogan et al. (2004)
BCL-1 β-lactams Antibiotic hydrolysis Chromosome Girlich et al. (2007)
cat (Bcl) Chloramphenicol Antibiotic acetylation Chromosome Galopin et al. (2009)
Biﬁdobacterium with QPS status (B. adolescentis, B. animalis, B.
biﬁdum, B. breve, and B. longum; EFSA, 2012) have not been linked
to any infective processes in healthy individuals. However, sev-
eral strains displaying antibiotic resistance phenotypes have been
characterized, and in many cases the phenotype has been linked
to speciﬁc antibiotic resistance genes, representing a potential risk
of transfer to other bacteria in the intestinal ecosystem (Ammor
et al., 2008b).
Biﬁdobacteria are intrinsically resistant to mupirocin, an
antibiotic that is being used in selective media for this genus.
Mupirocin competes with isoleucine as a substrate for isoleucyl-
tRNA synthetase, thus affecting protein synthesis. The resistance
phenotype of biﬁdobacteria is a consequence of the synthesis of an
atypical isoleucyl-tRNA synthetase that contains key amino acid
residues responsible for the high level of mupirocin resistance
(Seraﬁni et al., 2011). Furthermore, they are not susceptible to
high concentrations of aminoglycosides, most likely as a con-
sequence of the lack of cytochrome-mediated drug transport
(Mayrhofer et al., 2011). On the contrary, low concentra-
tions of macrolides, vancomycin, chloramphenicol, beta-lactams,
rifampicin, and spectinomycin, normally inhibit their growth
(Zhou et al., 2005; Lahtinen et al., 2009). However, it is worth
mentioning that a few streptomycin resistant strains have been
characterized, leading to the conclusion that the resistance phe-
notype in these strains is due to chromosomal mutations, and
not to the acquisition of speciﬁc antibiotic resistance genes, and
therefore do not represent a potential risk of transferability. Thus,
a high resistance to streptomycin was correlated with a mutation
on the rpsL gene for ribosomal protein S12 in B. biﬁdum and
B. breve (Kiwaki and Sato, 2009; Sato and Iino, 2010). Also, a
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B. biﬁdum strain displaying low erythromycin susceptibility was
found to possessmutated 23S ribosomal RNAgene copies, likely to
be responsible for the observed phenotype (Sato and Iino, 2010).
Data on antibiotic resistance determinants in biﬁdobacteria are
relatively scarce, and are limited to tetracycline and macrolide
antibiotics (Table 1). MDR proteins have been described in B.
longum and B. breve. The transporters are able to confer low resis-
tance levels to erythromycin, although their contribution to the
MLS phenotype remains to be determined (Margolles et al., 2005;
Price et al., 2006). Also, a gene coding for a ribosomal protection
protein, erm(X), was identiﬁed in B. animalis subsp. lactis and B.
thermophilum, as a part of the transposon Tn5432 (van Hoek et al.,
2008a).
Tetracycline resistance in Biﬁdobacterium deserves special
attention. We have known for more than a decade, that pro-
teins that protect the ribosome from the action of tetracyclines,
the so-called tet genes, are commonly found in this genus (Scott
et al., 2000; Gueimonde et al., 2010). The genes tet(W), tet(M),
tet(O), tet(W/32/O), and tet(O/W) have been detected in several
Biﬁdobacterium species, including B. longum (subsp. infantis and
subsp. longum), B. breve, B. animalis subsp. lactis, B. biﬁdum,
B. pseudocatenulatum, and B. thermophilum (Flórez et al., 2006;
Kazimierczak et al., 2006; Aires et al., 2007, 2009; Ammor et al.,
2008a; van Hoek et al., 2008b; Gueimonde et al., 2010). The gene
tet(W) is especially ubiquitous; it has been detected at high fre-
quencies in B. longum strains (Aires et al., 2007; Ammor et al.,
2008a), and in all B. animalis subsp. lactis strains analyzed until
now (Aires et al., 2007; Gueimonde et al., 2010). This last fact is
very relevant, taking into account that B. animalis subsp. lactis
strains are extensively used in the functional food industry, espe-
cially in fermented dairy products (Masco et al., 2005). The tet(W)
gene in Biﬁdobacterium seems to be integrated in the chromosome
and its surrounding regions vary depending on the strain, but very
often the gene is ﬂanked by transposase target sequences or genes
coding for transposases, enzymes that catalyze the movement of
DNA fragments betweendifferent locations by recognizing speciﬁc
target sequences, suggesting that, under adequate conditions, the
gene could be transferred (Kazimierczak et al., 2006; Ammor et al.,
2008a; van Hoek et al., 2008a,b; Gueimonde et al., 2010). In fact, a
tet(W) gene of B. longum, containing a transposase located within
the conserved upstream region of the gene, and ﬂanked by imper-
fect direct repeats, was transferable, at low frequencies, between
B. longum and B. adolescentis under in vitro conditions (Kazimier-
czak et al., 2006). This suggests the potential of biﬁdobacteria to
transfer antibiotic resistance genes to closely relatedbacteria. How-
ever, although attempts have been made to demonstrate the donor
capacity of biﬁdobacteria to other enteric bacteria, to the best of
our knowledge this has not been experimentally proved yet.
ANTIBIOTIC RESISTANCE GENES IN OTHER PROBIOTIC
STRAINS
Members of the genus Bacillus are aerobic or facultative aero-
bic, endospore-forming and rod-shaped Gram-positive bacteria,
which inhabit a wide range of habitats, mostly soil and sediments.
These bacteria do not belong to the commensal microbiota of the
gastrointestinal tract, but some strains of the genus are included
in food supplements and used in human nutrition as probiotics,
notably Bacillus clausii (Ciffo, 1984). Furthermore, several Bacil-
lus species have been employed for centuries in the manufacture
of traditional, fermented dishes in Africa and Asia (Sarkar et al.,
2002). Nowadays, certain Bacillus strains are used as feed addi-
tives, plant production products, biomass for animal feed, or
enzyme/vitamin production (SCAN, 2000; Hong et al., 2005), and
several species are included on the EFSA QPS list (EFSA, 2012).
Many characteristics of probiotic Bacillus strains differ from those
of other probiotic bacteria, including its ability to sporulate and
the mechanisms of interaction with the human intestinal mucosa
(Sánchez et al., 2009).
Regarding the presence of antibiotic-resistance mechanisms
in Bacillus, macrolide-resistance genes present on extra-
chromosomal elements have been identiﬁed in mobile elements,
such as the plasmid-encoded erm(C) fromBacillus subtilis (Monod
et al., 1986). Tetracycline resistance determinants have also been
found in mobile elements, including the plasmid-encoded tet(L)
gene from Bacillus subtilis (Phelan et al., 2011), and the tet(M)
gene, contained within the conjugative transposon Tn5397 of
Bacillus subtilis (Roberts et al., 1999). Other tetracycline resis-
tance genes, such as tet(K), have been observed in some Bacillus
isolates (Neela et al., 2009). Recently, the presence of cfr-like
genes in several Bacillus species has been reported. Cfr genes
encode ribosome methyltransferases providing resistance to sev-
eral classes of antibiotics including phenicols, oxazolidinone,
lincosamides, pleuromutilins, and streptogramin A (Dai et al.,
2010). However, these genes are not apparently expressed in the
species assayed, in spite of being fully functional in other bacte-
rial hosts (Hansen et al., 2012). In this regard, it is worth noting
the presence of speciﬁc antibiotic resistance mechanisms in cer-
tain Bacillus clausii strains, which have been used as probiotics in
humans, especially for the prevention of infectious bacterial diar-
rhea. For instance, the erm(34) gene has been identiﬁed in the
probiotic Bacillus clausii DSM8716 strain (Bozdogan et al., 2004).
Probiotic Bacillus clausii strains also harbor speciﬁc antibiotic-
defense mechanisms, such as an aminoglycoside resistance gene
(aadD2), a chloramphenicol acetyltransferase gene, cat(Bcl) or
a β-lactamase (BCL-1; Bozdogan et al., 2003; Girlich et al., 2007;
Galopin et al., 2009).
CONCLUSION
Bacteria naturally present in foods or food supplements, or delib-
erately added to them, including probiotic bacteria, constitute
a potential source of antibiotic resistance determinants. Espe-
cially some fermented foods, such as dairy products, possess an
extremely high bacterial density, mostly composed of LAB, quan-
titatively comparablewith themicrobial population found in some
parts of the human intestine. Thismicrobial population represents
a huge reservoir of antibiotic resistance genes whose ingestion
could inﬂuence the presence, establishment, and dynamics of
antibiotic resistance bacteria in our body.
ACKNOWLEDGMENTS
We acknowledge the continuous support from the Plan Nacional
de I+D through several grants. Borja Sánchez was the recipient
of a Juan de la Cierva postdoctoral contract from the Spanish
Ministerio de Ciencia e Innovación.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy July 2013 | Volume 4 | Article 202 | 4
“fmicb-04-00202” — 2013/7/16 — 20:41 — page 5 — #5
Gueimonde et al. Antibiotic resistance in probiotic bacteria
REFERENCES
Ahn, C., Collins-Thompson, D., Dun-
can, C., and Stiles, M. E. (1992).
Mobilization and location of the
genetic determinant of chloram-
phenicol resistance from Lactobacil-
lus plantarum caTC2R. Plasmid 27,
169–176. doi: 10.1016/0147-619X
(92)90018-6
Aires, J., Doucet-Populaire, F., and
Butel, M. J. (2007). Tetracycline resis-
tance mediated by tet(W), tet(M),
and tet(O) genes of Biﬁdobacterium
isolates from humans. Appl. Envi-
ron. Microbiol. 73, 2751–2754. doi:
10.1128/AEM.02459-06
Aires, J., Thouverez, M., Doucet-
Populaire, F., and Butel, M. J. (2009).
Consecutive human biﬁdobacteria
isolates and acquired tet genes. Int. J.
Antimicrob. Agents 33, 291–293. doi:
10.1016/j.ijantimicag.2008.09.013
Ammor, M. S., Flórez, A. B., Alvarez-
Martín, P., Margolles, A., and
Mayo, B. (2008a). Analysis of tetra-
cycline resistance tet(W) genes and
their ﬂanking sequences in intestinal
Biﬁdobacterium species. J. Antimi-
crob. Chemother. 62, 688–693. doi:
10.1093/jac/dkn280
Ammor, M. S., Flórez, A. B., Van Hoek,
A. H. A. M., de los Reyes-Gavilán,
C. G., Aarts, H. J. M., Margolles,
A., et al. (2008b). Molecular charac-
terization of intrinsic and acquired
antibiotic resistance in lactic acid
bacteria and biﬁdobacteria. J. Mol.
Microbiol. Biotechnol. 14, 6–15.
Ammor, M. S., Gueimonde, M.,
Danielsen, M., Zagorec, M., van
Hoek, A. H., de los Reyes-Gavilán,
C. G., et al. (2008c). Two differ-
ent tetracycline resistance mecha-
nisms, plasmid-carried tet(L) and
chromosomally located transposon-
associated tet(M), coexist in Lacto-
bacillus sakei Rits 9. Appl. Environ.
Microbiol. 74, 1394–1401. doi:
10.1128/AEM.01463-07
Aquilanti, L., Garofalo, C., Osi-
mani, A., Silvestri, G., Vignaroli,
C., and Clementi, F. (2007). Iso-
lation and molecular characteriza-
tion of antibiotic-resistant lactic acid
bacteria from poultry and swine
meat products. J. Food Prot. 70,
557–565.
Barberis, C. M., Cittadini, R. M.,
Almuzara, M. N., Feinsilberg, A.,
Famiglietti, A. M., Ramírez, M. S.,
et al. (2012). Recurrent urinary infec-
tion with Biﬁdobacterium scardovii. J.
Clin. Microbiol. 50, 1086–1088. doi:
10.1128/JCM.06027-11
Bennedsen, M., Stuer-Lauridsen, B.,
Danielsen, M., and Johansen, E.
(2011). Screening for antimicrobial
resistance genes and virulence factors
via genome sequencing. Appl. Envi-
ron. Microbiol. 77, 2785–2787. doi:
10.1128/AEM.02493-10
Bozdogan, B., Galopin, S., Gerbaud, G.,
Courvalin, P., andLeclercq,R. (2003).
Chromosomal aadD2 encodes
an aminoglycoside nucleotidyl-
transferase in Bacillus clausii.
Antimicrob. Agents Chemother. 47,
1343–1346. doi: 10.1128/AAC.47.4.
1343-1346.2003
Bozdogan, B., Galopin, S., and
Leclercq, R. (2004). Characteriza-
tion of a new erm-related macrolide
resistance gene present in pro-
biotic strains of Bacillus clausii.
Appl. Environ. Microbiol. 70, 280–
284. doi: 10.1128/AEM.70.1.280-
284.2004
Cannon, J. P., Lee, T. A., Bolanos,
J. T., and Danziger, L. H. (2005).
Pathogenic relevance of Lactobacil-
lus: a retrospective review of over 200
cases. Eur. J. Clin. Microbiol. Infect.
Dis. 24, 31–40. doi: 10.1007/s10096-
004-1253-y
Cauwerts, K., Pasmans, F., Devriese, L.
A., Martel, A., Haesebrouck, F., and
Decostere, A. (2006). Cloacal Lacto-
bacillus isolates from broilers show
high prevalence of resistance towards
macrolide and lincosamide antibi-
otics. Avian Pathol. 35, 160–164. doi:
10.1080/03079450600598137
Ciffo, F. (1984). Determination of
the spectrum of antibiotic resis-
tance of the “Bacillus subtilis” strains
of Enterogermina. Chemioterapia 3,
45–52.
Dai, L., Wu, C. M., Wang, M. G.,
Wang, Y., Wang, Y., Huang, S.
Y., et al. (2010). First report of
the multidrug resistance gene cfr
and the phenicol resistance gene
fexA in a Bacillus strain from swine
feces. Antimicrob. Agents Chemother.
54, 3953–3955. doi: 10.1128/AAC.
00169-10
Delcour, J., Ferain, T., Deghorain, M.,
Palumbo, E., and Hols, P. (1999).
The biosynthesis and functionality
of the cell-wall of lactic acid bac-
teria. Antonie Van Leeuwenhoek 76,
159–184. doi: 10.1023/A:1002089
722581
Devirgiliis, C., Coppola, D., Bar-
ile, S., Colonna, B., and Perozzi,
G. (2009). Characterization of the
Tn916 conjugative transposon in a
food-borne strain of Lactobacillus
paracasei. Appl. Environ. Microbiol.
75, 3866–3871. doi: 10.1128/AEM.
00589-09
EFSA. (2008). Update of the criteria
used in the assessment of bacterial
resistance to antibiotics of human
or veterinary importance. EFSA J.
732, 1–15.
EFSA. (2012). Scientiﬁc opinion on the
maintenance of the list of QPS bio-
logical agents intentionally added to
food and feed. EFSA J. 10, 3020.
doi:10.2903/j.efsa.2011.2497
Egervärn, M., Roos, S., and Lind-
mark, H. (2009). Identiﬁcation and
characterization of antibiotic resis-
tance genes in Lactobacillus reuteri
and Lactobacillus plantarum. J. Appl.
Microbiol. 107, 1658–1668. doi:
10.1111/j.1365-2672.2009.04352.x
Feld, L., Schjorring, S., Hammer, K.,
Licht, T. R., Danielsen, M., Krogfelt,
K., et al. (2008). Selective pressure
affects transfer and establishment of
a Lactobacillus plantarum resistance
plasmid in the gastrointestinal envi-
ronment. J. Antimicrob. Chemother.
61, 845–852. doi: 10.1093/jac/dkn033
Flórez, A. B., Ammor, M. S., Alvarez-
Martín, P., Margolles, A., and
Mayo, B. (2006). Molecular analysis
of tet(W) gene-mediated tetracycline
resistance in dominant intestinal Biﬁ-
dobacterium species from healthy
humans. Appl. Environ. Microbiol. 72,
7377–7379.
Flórez,A. B., Ladero,V.,Alvarez-Martín,
P., Ammor, M. S., Alvarez, M. A., and
Mayo, B. (2007). Acquired macrolide
resistance in the human intestinal
strain Lactobacillus rhamnosus E41
associated with a transition mutation
in 23S rRNA genes. Int. J. Antimicrob.
Agents 30, 341–344.
Galopin, S., Cattoir, V., and Leclercq,
R. (2009). A chromosomal chlo-
ramphenicol acetyltransferase deter-
minant from a probiotic strain of
Bacillus clausii. FEMS Microbiol. Lett.
296, 185–189. doi: 10.1111/j.1574-
6968.2009.01633.x
Gfeller, K. Y., Roth, M., Meile, L.,
and Teuber, M. (2003). Sequence
and genetic organization of the 19.3-
kb erythromycin- and dalfopristin-
resistance plasmid pLME300 from
Lactobacillus fermentum ROT1. Plas-
mid 50, 190–201. doi: 10.1016/
j.plasmid.2003.08.001
Girlich, D., Leclercq, R., Naas, T.,
and Nordmann, P. (2007). Molec-
ular and biochemical characteriza-
tion of the chromosome-encoded
class Aβ-Lactamase BCL-1 from
Bacillus clausii. Antimicrob. Agents
Chemother. 51, 4009–4014. doi:
10.1128/AAC.00537-07
Gouriet, F., Million, M., Henri, M.,
Fournier, P. E., and Raoult, D. (2012).
Lactobacillus rhamnosus bacteremia:
an emerging clinical entity. Eur. J.
Clin. Microbiol. Infect. Dis. 31, 2469–
2480. doi: 10.1007/s10096-012-
1599-5
Gueimonde, M., Flórez, A. B., de los
Reyes-Gavilán, C. G., and Margolles,
A. (2009). Intrinsic resistance in lac-
tic acid bacteria and biﬁdobacteria:
the role of multidrug resistance trans-
porters. Int. J. Probiotics Prebiotics 4,
181–186.
Gueimonde,M., Flórez,A. B., vanHoek,
A. H., Stuer-Lauridsen, B., Strø-
man, P., de los Reyes-Gavilán, C. G.,
et al. (2010). Genetic basis of tetra-
cycline resistance in Biﬁdobacterium
animalis subsp. lactis. Appl. Environ.
Microbiol. 76, 3364–3369.
Hansen, F., Sorensen, J., Giese, H.,
Sondergaard, T., and Frandsen, R.
(2012). Quick guide to polyke-
tide synthase and nonribosomal syn-
thetase genes in Fusarium. Int. J.
Food Microbiol. 155, 128–136. doi:
10.1016/j.ijfoodmicro.2012.01.018
Hong, H. A., le Duc, H., and Cutting,
S. M. (2005). The use of bacterial
spore formers as probiotics. FEMS
Microbiol. Rev. 29, 813–835. doi:
10.1016/j.femsre.2004.12.001
Hummel, A. S., Hertel, C., Holzapfel,
W. H., and Franz, C. M. (2007).
Antibiotic resistances of starter and
probiotic strains of lactic acid bac-
teria. Appl. Environ. Microbiol.
73, 730–739. doi: 10.1128/AEM.
02105-06
Jenke, A., Ruf, E. M., Hoppe, T., Held-
mann, M., and Wirth, S. (2012).
Biﬁdobacterium septicaemia in an
extremely low-birthweight infant
under probiotic therapy. Arch. Dis.
Child Fetal Neonatal Ed. 97, F217–
F218. doi: 10.1136/archdischild-
2011-300838
Kazimierczak, K. A., Flint, H. J.,
and Scott, K. P. (2006). Compar-
ative analysis of sequences ﬂanking
tet(W) resistance genes in multiple
species of gut bacteria. Antimicrob.
Agents Chemother. 50, 2632–2639.
doi: 10.1128/AAC.01587-05
Kiwaki, M., and Sato, T. (2009).
Antimicrobial susceptibility of Biﬁ-
dobacterium breve strains and genetic
analysis of streptomycin resistance
of probiotic B. breve strain Yakult.
Int. J. Food Microbiol. 134, 211–
215. doi: 10.1016/j.ijfoodmicro.2009.
06.011
Klare, I., Konstabel, C., Werner,
G., Huys, G., Vankerckhoven,
V., Kahlmeter, G., et al. (2007).
Antimicrobial susceptibilities of Lac-
tobacillus, Pediococcus and Lacto-
coccus human isolates and cultures
intended for probiotic or nutri-
tional use. J. Antimicrob. Chemother.
59, 900–912. doi: 10.1093/jac/
dkm035
Korhonen, J. M., Danielsen, M.,
Mayo, B., Egervarn, H., Axelsson,
L., Huys, G., et al. (2008). Antimi-
crobial susceptibility and proposed
www.frontiersin.org July 2013 | Volume 4 | Article 202 | 5
“fmicb-04-00202” — 2013/7/16 — 20:41 — page 6 — #6
Gueimonde et al. Antibiotic resistance in probiotic bacteria
microbiological cut-off values of lac-
tobacilli by phenotypic determina-
tion. Int. J. Probiotics Prebiotics 3,
257–268.
Lahtinen, S. J., Boyle, R. J.,Margolles,A.,
Frías, R., and Gueimonde, M. (2009).
“Safety assessment of probiotics,” in
Prebiotics and Probiotics Science and
Technology, eds D. Charalampopou-
los andR.A.Rastall (Berlin: Springer-
Verlag), 1193–1225.
Lin, C. F., Fung, Z. F., Wu, C. L.,
and Chung, T. C. (1996). Molecular
characterization of a plasmid-borne
(pTC82) chloramphenicol resistance
determinant (cat-TC) from Lacto-
bacillus reuteri G4. Plasmid 36, 116–
124. doi: 10.1006/plas.1996.0039
Margolles, A., Moreno, J. A., van
Sinderen, D., and de los Reyes-
Gavilán, C. G. (2005). Macrolide
resistance mediated by a Biﬁdobac-
terium breve membrane protein.
Antimicrob. Agents Chemother. 49,
4379–4381. doi: 10.1128/AAC.49.10.
4379-4381.2005
Masco, L., Huys, G., De Brandt,
E., Temmerman, R., and Swings,
J. (2005). Culture-dependent and
culture-independent qualitative anal-
ysis of probiotic products claimed
to contain biﬁdobacteria. Int. J.
Food Microbiol. 102, 221–230. doi:
10.1016/j.ijfoodmicro.2004.11.018
Mater, D. D., Langella, P., Corthier, G.,
and Flores, M. J. (2008). A probi-
otic Lactobacillus strain can acquire
vancomycin resistance during diges-
tive transit in mice. J. Mol. Micro-
biol. Biotechnol. 14, 123–127. doi:
10.1159/000106091
Mayrhofer, S., Mair, C., Kneifel, W.,
and Domig, K. J. (2011). Suscepti-
bility of biﬁdobacteria of animal ori-
gin to selected antimicrobial agents.
Chemother. Res. Pract. 989520. doi:
10.1155/2011/989520
Mayrhofer, S., van Hoeck, A. H.
A. M., Mair, C., Huys, G.,
Arts, H. J. M., Kneifel, W., et al.
(2010). Antibiotic susceptibility of
members of the Lactobacillus aci-
dophilus group using broth microdi-
lution and molecular identiﬁcation
of their resistance determinants.
Int. J. Food Microbiol. 144, 81–
87. doi: 10.1016/j.ijfoodmicro.2010.
08.024
Monod, M., Denoya, C., and Dubnau,
D. (1986). Sequence and properties
of pIM13, a macrolide-lincosamide-
streptogramin B resistance plasmid
fromBacillus subtilis. J. Bacteriol. 167,
138–147.
Neela, F. A., Nonaka, L., Rahman, M.
H., and Suzuki, S. (2009). Trans-
fer of the chromosomally encoded
tetracycline resistance gene tet(M)
from marine bacteria to Escherichia
coli and Enterococcus faecalis. World J.
Microbiol. Biotechnol. 25, 1095–1101.
doi: 10.1007/s11274-009-0004-8
Ohishi, A., Takahashi, S., Ito, Y.,
Ohishi, Y., Tsukamoto, K., Nanba,
Y., et al. (2010). Biﬁdobacterium sep-
ticemia associated with postoperative
probiotic therapy in a neonate with
omphalocele. J. Pediatr. 156, 679–
681. doi: 10.1016/j.jpeds.2009.11.041
Phelan, R. W., Clarke, C., Morrissey,
J. P., Dobson, A. D., O’Gara, F.,
and Barbosa, T. M. (2011). Tetra-
cycline resistance-encoding plasmid
from Bacillus sp. strain #24, iso-
lated from the marine sponge Hali-
clona simulans. Appl. Environ. Micro-
biol. 77, 327–329. doi: 10.1128/AEM.
01239-10
Price, C. E., Reid, S. J., Driessen,
A. J., and Abratt, V. R. (2006).
The Biﬁdobacterium longum NCIMB
702259Tctr gene codes for a novel
cholate transporter. Appl. Envi-
ron. Microbiol. 72, 923–926. doi:
10.1128/AEM.72.1.923-926.2006
Roberts, A. P., Pratten, J., Wilson, M.,
and Mullany, P. (1999). Transfer of a
conjugative transposon, Tn5397 in a
model oral bioﬁlm. FEMS Microbiol.
Lett. 177, 63–66. doi: 10.1111/j.1574-
6968.1999.tb13714.x
Rojo-Bezares, B., Sáenz, Y., Poeta, P.,
Zarazaga, M., Ruiz-Larrea, F., and
Torres, C. (2006). Assessment of
antibiotic susceptibility within lac-
tic acid bacteria strains isolated from
wine. Int. J. Food Microbiol. 111,
234–240.
Sakamoto, K., Margolles, A., van
Veen, H. W., and Konings, W. N.
(2001). Hop resistance in the beer
spoilage bacterium Lactobacillus bre-
vis is mediated by the ATP-binding
cassette multidrug transporter HorA.
J. Bacteriol. 183, 5371–5375. doi:
10.1128/JB.183.18.5371-5375.2001
Sánchez, B., Arias, S., Chaigne-
pain, S., Denayrolles, M., Schmit-
ter, J. M., Bressollier, P., et al.
(2009). Identiﬁcation of surface pro-
teins involved in the adhesion of
a probiotic Bacillus cereus strain to
mucin and ﬁbronectin. Microbiology
155, 1708–1716. doi: 10.1099/mic.0.
025288-0
Sánchez, B., Ruiz, L., Gueimonde,
M., Ruas-Madiedo, P., and Mar-
golles, A. (2013). Adaptation of
biﬁdobacteria to the gastrointestinal
tract and functional consequences.
Pharmacol. Res. 69, 127–136. doi:
10.1016/j.phrs.2012.11.004
Sarkar, P. K.,Hasenack, B., andNout,M.
J. (2002). Diversity and functionality
of Bacillus and related genera iso-
lated from spontaneously fermented
soybeans (Indian Kinema) and locust
beans (African Soumbala). Int. J.
Food Microbiol. 77, 175–186. doi:
10.1016/S0168-1605(02)00124-1
Sato, T., and Iino, T. (2010). Genetic
analyses of the antibiotic resis-
tance of Biﬁdobacterium biﬁdum
strain Yakult YIT 4007. Int. J.
Food Microbiol. 137, 254–258. doi:
10.1016/j.ijfoodmicro.2009.12.014
SCAN (Scientiﬁc Committee on
Animal Nutrition, European Com-
mission). (2000). Opinion on the
Safety of Use of Bacillus Species
in Animal Nutrition. Available at:
http://ec.europa.eu/food/fs/sc/scan/
out41_en.pdf.
Scott, K. P., Melville, C. M., Bar-
bosa, T. M., and Flint, H. J. (2000).
Occurrence of the new tetracycline
resistance gene tet(W) in bacteria
from the human gut. Antimicrob.
Agents Chemother. 44, 775–777. doi:
10.1128/AAC.44.3.775-777.2000
Seraﬁni, F., Bottacini, F., Viappiani, A.,
Barufﬁni, E., Turroni, F., Foroni, E.,
et al. (2011). Insights into physiolog-
ical and genetic mupirocin suscepti-
bility in biﬁdobacteria. Appl. Envi-
ron. Microbiol. 77, 3141–3146. doi:
10.1128/AEM.02540-10
Suzuki, K., Iijima, K., Ozaki, K.,
and Yamashita, H. (2005). Isolation
of a hop-sensitive variant of Lacto-
bacillus lindneri and identiﬁcation of
geneticmarkers for beer spoilage abil-
ity of lactic acid bacteria. Appl. Env-
iron. Microbiol. 71, 5089–5097. doi:
10.1128/AEM.71.9.5089-5097.2005
Tannock, G. W., Luchansky, J. B., Miller,
L., Connell, H., Thode-Andersen, S.,
Mercer, A. A., et al. (1994). Molecular
characterization of a plasmid-borne
(pGT633) erythromycin resistance
determinant (ermGT) from Lacto-
bacillus reuteri 100-63. Plasmid 31,
60–71. doi: 10.1006/plas.1994.1007
Thumu, S. C., and Halami, P. M.
(2012). Presence of erythromycin
and tetracycline resistance genes in
lactic acid bacteria from fermented
foods of Indian origin. Antonie Van
Leeuwenhoek 102, 541–551. doi:
10.1007/s10482-012-9749-4
van Hoek, A. H., Mayrhofer, S., Domig,
K. J., and Aarts, H. J. (2008a). Resis-
tance determinant erm(X) is borne
by transposon Tn5432 in Biﬁdobac-
terium thermophilum and Biﬁdobac-
terium animalis subsp. lactis. Int. J.
Antimicrob. Agents. 31, 544–548. doi:
10.1016/j.ijantimicag.2008.01.025
van Hoek, A. H., Mayrhofer, S.,
Domig, K. J., Flórez, A. B., Ammor,
M. S., Mayo, B., et al. (2008b).
Mosaic tetracycline resistance
genes and their ﬂanking regions
in Biﬁdobacterium thermophilum and
Lactobacillus johnsonii. Antimi-
crob. Agents Chemother. 52,
248–252.
van Hoek, A. H. A. M., Margolles, A.,
Damig, K. J., Korhonen, J. M., Zycka-
Krzesinka, J., Bardowsky, J., et al.
(2008c). Molecular assessment of
erythromycin and tetracycline resis-
tance genes in lactic acid bacteria
and biﬁdobacteria and their relation
to the phenotypic resistance. Int. J.
Probiotics Prebiotics 3, 271–280.
Vescovo, M., Morelli, L., Bottazzi, V.,
and Gasson, M. J. (1983). Conju-
gal transfer of broad-host-range plas-
mid pAMbeta1 into enteric species
of lactic acid bacteria. Appl. Environ.
Microbiol. 46, 753–755.
Whitehead, K., Versalovic, J., Roos,
S., and Britton, R. A. (2008).
Genomic and genetic characteriza-
tion of the bile stress response of
probiotic Lactobacillus reuteri ATCC
55730. Appl. Environ. Microbiol.
74, 1812–1819. doi: 10.1128/AEM.
02259-07
Zhou, J. S., Pillidge, C. J., Gopal, P.
K., and Gill, H. S. (2005). Antibi-
otic susceptibility proﬁles of new
probiotic Lactobacillus and Biﬁdobac-
terium strains. Int. J. Food Micro-
biol. 98, 211–217. doi: 10.1016/
j.ijfoodmicro.2004.05.011
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 28 March 2013; paper pend-
ing published: 17 April 2013; accepted:
28 June 2013; published online: 18 July
2013.
Citation: Gueimonde M, Sánchez B, de
los Reyes-Gavilán CG and Margolles A
(2013) Antibiotic resistance in probiotic
bacteria. Front. Microbiol. 4:202. doi:
10.3389/fmicb.2013.00202
This article was submitted to Fron-
tiers in Antimicrobials, Resistance and
Chemotherapy, a specialty of Frontiers in
Microbiology.
Copyright © 2013 Gueimonde, Sánchez,
de los Reyes-Gavilán and Margolles. This
is an open-access article distributed under
the terms of the Creative Commons
Attribution License, which permits use,
distribution and reproduction in other
forums, provided the original authors and
source are credited and subject to any
copyright notices concerning any third-
party graphics etc.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy July 2013 | Volume 4 | Article 202 | 6
